| Cross-reactive antibodies to SARS-CoV-2 and MERS-CoV in pre-COVID-19 blood samples from Sierra Leoneans R Borrega, DKS Nelson, AP Koval, NG Bond, ML Heinrich, MM Rowland, ... Viruses 13 (11), 2325, 2021 | 31 | 2021 |
| A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus RW Cross, ML Heinrich, KA Fenton, V Borisevich, KN Agans, AN Prasad, ... Proceedings of the National Academy of Sciences 120 (34), e2304876120, 2023 | 10 | 2023 |
| Systematic review and principal components analysis of the immunogenicity of adalimumab R Borrega, C Araújo, N Aguiam, F Magro, JE Fonseca, S Danese, J Lopes, ... BioDrugs 35, 35-45, 2021 | 7 | 2021 |
| Analysis of immunogenicity data in the product information of biological drugs: a need to report immunogenicity data systematically R Borrega, JP Cruz, P Taylor, J Goncalves BioDrugs 33, 683-691, 2019 | 5 | 2019 |
| Circumstances of the ambulatory prescription of quinolones in Urology and opportunities for intervention V Tiago, D Sousa, J Luque, MJ Rei, R Borrega, M Cabedal, PO Raimundo Journal of Healthcare Quality Research 37 (4), 254-262, 2022 | 2 | 2022 |
| Biosimilars: An Opportunity to Update the Product Information of Biological Drugs Regarding their Immunogenicity R Borrega, JP Cruz, P Taylor, J Goncalves BioDrugs 33, 693-695, 2019 | 1 | 2019 |
| Journal of Healthcare Quality Research V Tiago, D Sousa, J Luque, MJ Rei, R Borrega, M Cabedal, PO Raimundo mortality 1, 2, 2021 | | 2021 |
